ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,499, issued on May 6, was assigned to Cybin IRL Ltd. (Dublin).
"Deuterated tryptamine derivatives and methods of use" was invented by Alex Nivorozhkin (West Roxbury, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor."
The patent was filed on March 8, 2024, under Application No. 18/600,018.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&...